Blood Based Genomic Signature Screening – Panel of 8 Cancers

Why BGS?
For the first time, detect cancer risks at a very early stage with BGS, a revolutionary blood test using circulating RNA to assess your risk for 8 Common Cancers. Using only gold standard and FDA-approved reagents and instruments, BGS ensures unparalleled result quality.

Who Should Consider BGS?
Adults aged over 25 years old, especially those with a family history of cancer. BGS is your proactive step towards understanding and managing your health risks.

Key Features:
> Detects 8 cancers: Nasopharyngeal, Lung, Stomach, Liver, Colon, Breast, Cervical, Prostate.
>Non-Invasive: No uncomfortable procedures; a simple blood test is all it takes.

Curious? Reach out to us!
Call: +603 6141 8533
WhatsApp: +6012 527 7440
Visit: www.alphaspecialist.com